"Fatigue" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
| Descriptor ID |
D005221
|
| MeSH Number(s) |
C23.888.369
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fatigue".
Below are MeSH descriptors whose meaning is more specific than "Fatigue".
This graph shows the total number of publications written about "Fatigue" by people in this website by year, and whether "Fatigue" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 |
| 1997 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 1 | 2 | 3 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 1 | 3 |
| 2006 | 3 | 1 | 4 |
| 2007 | 3 | 3 | 6 |
| 2008 | 1 | 3 | 4 |
| 2009 | 4 | 3 | 7 |
| 2010 | 2 | 4 | 6 |
| 2011 | 3 | 3 | 6 |
| 2012 | 2 | 4 | 6 |
| 2013 | 1 | 5 | 6 |
| 2014 | 0 | 6 | 6 |
| 2015 | 4 | 3 | 7 |
| 2016 | 0 | 4 | 4 |
| 2017 | 3 | 6 | 9 |
| 2018 | 4 | 4 | 8 |
| 2019 | 1 | 5 | 6 |
| 2020 | 1 | 5 | 6 |
| 2021 | 0 | 4 | 4 |
| 2022 | 1 | 9 | 10 |
| 2023 | 0 | 5 | 5 |
| 2024 | 1 | 4 | 5 |
| 2025 | 1 | 2 | 3 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fatigue" by people in Profiles.
-
Depression severity and discordance between fatigue patient-reported outcomes in people with multiple sclerosis. Mult Scler Relat Disord. 2026 Jun; 110:107192.
-
Real or Not Real? An Elevated TSH. J Investig Med High Impact Case Rep. 2026 Jan-Dec; 14:23247096261430087.
-
Central and peripheral fatigue indices following resistance exercise with and without blood flow restriction among people with multiple sclerosis. J Neurophysiol. 2025 Sep 01; 134(3):843-855.
-
Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 Sequelae. J Infect Dis. 2025 Jul 30; 232(1):39-49.
-
Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn's Disease in the Phase 2 AMAG Study. Inflamm Bowel Dis. 2025 02 06; 31(2):432-441.
-
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors. N Engl J Med. 2025 Feb 13; 392(7):653-665.
-
Mild Primary or Breakthrough SARS-CoV-2 Infection Promotes Autoantibody Production in Individuals with and without Neuro-PASC. Immunohorizons. 2024 08 01; 8(8):577-585.
-
Assessing the longevity of attribute framing in attenuating the nocebo effect to brand and generic medication. Appl Psychol Health Well Being. 2024 11; 16(4):2026-2047.
-
SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-up. PLoS One. 2024; 19(4):e0297481.
-
Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias. Mov Disord Clin Pract. 2024 05; 11(5):496-503.